Identification of STX-721, an EGFR exon 20 mutant inhibitor with superior selectivity and a potential best-in-class profile. (October 2022) - Pagliarini, R.; Milgram, B.C.; Borrelli, D.R.; Brooijmans, N.; Huff, M.R.; Ito, T.; Jonsson, P.; Ladd, B.; O'Hearn, E.; Wang, W.; Kuzmic, P.; Bellier, J.; et al.